Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan flag Japan · Delayed Price · Currency is JPY
6,734.00
-456.00 (-6.34%)
Nov 6, 2026, 11:30 AM JST

Chugai Pharmaceutical Cash Flow Statement

Millions JPY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
503,712434,012387,317325,472374,429302,995
Depreciation & Amortization
34,43532,53531,66531,74031,43430,868
Loss (Gain) From Sale of Assets
-8,0274,5274,377-21,8816416,342
Other Operating Activities
4,036-190,078-101,510-180,718-152,074-104,102
Change in Other Net Operating Assets
-111,761105,284125,751255,312-10,31843,523
Operating Cash Flow
435,432386,280447,600409,925244,112279,626
Operating Cash Flow Growth
6.31%-13.70%9.19%67.92%-12.70%36.38%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-74,149-76,273-50,415-71,948-62,625-65,969
Sale of Property, Plant & Equipment
2247,509-51019,3461,0481,042
Sale (Purchase) of Intangibles
-29,300-35,306-1,68512,850-8,614-6,897
Investment in Securities
-51,045-100,804-177,539979-76,083-47,236
Other Investing Activities
6,1253,6012,7841,483280133
Investing Cash Flow
-148,145-201,273-227,365-37,290-145,994-118,927

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
74142168217241322
Repurchase of Common Stock
-3,936-6-10-5-5-8
Common Dividends Paid
-350,372-299,419-133,249-131,594-138,220-98,644
Other Financing Activities
-560-8,603-7,915-7,949-7,657-9,078
Financing Cash Flow
-364,043-307,886-141,006-139,331-145,641-107,408

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
2,6299,2792,2993,2021,9392,128
Miscellaneous Cash Flow Adjustments
----1--
Net Cash Flow
-74,127-113,60081,528236,505-45,58455,419

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
361,283310,007397,185337,977181,487213,657
Free Cash Flow Growth
3.12%-21.95%17.52%86.23%-15.06%44.37%
Free Cash Flow Margin
25.54%24.64%33.93%30.41%14.40%21.37%
Free Cash Flow Per Share
219.54188.37241.36205.40110.30129.87
Levered Free Cash Flow
212,726263,045338,816317,041148,160177,704
Unlevered Free Cash Flow
212,785263,175338,813317,058148,198177,734

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
56142994815848
Cash Income Tax Paid
176,601191,104100,477176,074152,082104,074
Change in Working Capital
-111,761105,284125,751255,312-10,31843,523